As of Feb 12
| +0.86 / +7.73%|
The 4 analysts offering 12-month price forecasts for Innoviva Inc have a median target of 10.50, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a -12.43% decrease from the last price of 11.99.
The current consensus among 5 polled investment analysts is to Hold stock in Innoviva Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.